Sesen Bio's Series A - II Round

Sesen Bio raised a round of funding on May 08, 2012.

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.…

Articles about Sesen Bio's Series A - II Round: